BGB-16673
N/A
Report date: 2026/04/14 20:00:15
NME
Base Information
Drug NameBGB-16673
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[30]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeOne Medicines Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesBeOne Medicines LtdThe University Of Texas MD Anderson Cancer CenterBeigene (Suzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications +[12]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A